Literature DB >> 27023476

Effect of endourological procedures on erectile function: a prospective cohort study.

Ashraf Mosharafa1, Mahmoud Abd El Hamid2, Mohamed Tawfik1, Omar Abd El Rzzak1.   

Abstract

INTRODUCTION: Many patients offered endourological procedures are concerned about potential sexual dysfunction following endoscopy, and there are scarce published data to support an evidence-based response. We aim to assess possible effects of endourological procedures on sexual activity and erectile function. PATIENTS AND METHODS: Sexually active men undergoing cystoscopy and/or upper tract endourological procedures were enrolled and evaluated using the IIEF-5 score and the IPSS, filled the day before and 10 days and 45-60 days after the procedure. Patients' characteristics (age, chronic medical condition, smoking, and medications) were recorded. The primary outcome was the change in the IIEF-5 score.
RESULTS: One hundred patients aged 24-60 years (mean 37.4) underwent endourological procedures (42 PCNLs, 30 ureteroscopies, 22 retrograde ureteropyelographies ± stenting, and 6 cystolitholapaxies) between January and August 2014. Preoperative IPSS ranged from 0 to 32 (mean [SD] 11.93 [8.64]), while IIEF-5 ranged from 14 to 25 (mean [SD] 21.63 [2.96]), with eight patients in the mild to moderate (12-16) ED range, 31 mild ED (17-21), and 59 no ED (22-25). Following the procedure, the IPSS improved (mean IPSS down from 11.9 to 6.1 at 10 days and 6.2 at 45 days, P < 0.001), while the IIEF remained unchanged [21.6 preoperative to 21.0 at 10 days (P = 0.43) and 21.7 at 45 days (P = 0.81)]. Patients with indwelling ureteric stents (28 patients) had significant LUTS postoperatively with a mean [SD] IPSS of 9.8 [7.2] at 10 days and 11.6 [7.8] at 45 days. The IIEF-5 score was not affected with a mean [SD] of 21.5 [3.3] at 10 days and 21.8 [3.1] at 45 days, compared to 22.0 [3.0] preoperatively (P = 0.44).
CONCLUSION: Endoscopic procedures did not negatively impact erectile function and sexual activity.

Entities:  

Keywords:  Endourology; Erectile function; IIEF; Stents

Mesh:

Year:  2016        PMID: 27023476     DOI: 10.1007/s11255-016-1274-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

Review 1.  Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

Authors:  Raymond C Rosen; Francois Giuliano; Culley C Carson
Journal:  Eur Urol       Date:  2005-01-05       Impact factor: 20.096

2.  Endourological procedures and sexual dysfunction: a prospective multivariate analysis.

Authors:  Mario Sofer; Ravit Yehiely; Alexander Greenstein; Yuval Bar-Yosef; Haim Matzkin; Juza Chen
Journal:  BJU Int       Date:  2011-04-20       Impact factor: 5.588

3.  Ureteral stents: morbidity and impact on quality of life.

Authors:  Dan Leibovici; Amir Cooper; Arie Lindner; Regina Ostrowsky; Judy Kleinmann; Sergey Velikanov; Helio Cipele; Eliahu Goren; Yoram I Siegel
Journal:  Isr Med Assoc J       Date:  2005-08       Impact factor: 0.892

4.  Adverse effects of cystoscopy and its impact on patients' quality of life and sexual performance.

Authors:  Kobi Stav; Dan Leibovici; Elyahu Goren; Anna Livshitz; Yoram I Siegel; Arie Lindner; Amnon Zisman
Journal:  Isr Med Assoc J       Date:  2004-08       Impact factor: 0.892

5.  Lower urinary tract symptoms (LUTS) and sexual function in both sexes.

Authors:  Bjarne Lühr Hansen
Journal:  Eur Urol       Date:  2004-08       Impact factor: 20.096

6.  Indwelling ureteral stents and sexual health: a prospective, multivariate analysis.

Authors:  M C Sighinolfi; S Micali; S De Stefani; A Mofferdin; M Grande; A Grande; M Giacometti; N Ferrari; M Rivalta; G Bianchi
Journal:  J Urol       Date:  2007-05-17       Impact factor: 7.450

  6 in total
  1 in total

1.  Impact of Endourological procedures with or without double-J stent on sexual function: a systematic review and meta-analysis.

Authors:  Junlin Lu; Yinghong Lu; Yang Xun; Fan Chen; Shaogang Wang; Shiyi Cao
Journal:  BMC Urol       Date:  2020-02-14       Impact factor: 2.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.